CORONA Remedies
CORONANSE

CORONA Remedies

₹1,781.80-38.40 (2.11%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,776.00
Today’s high
1,864.00
52 week low
1,336.60
52 week high
1,949.40
Open price
1,829.30
Previous close
1,820.20
Live volume
54,888
Lower circuit
1,425.50
Upper circuit
2,138.10

Fundamentals

Market Cap
₹11,138Cr
ROE
24.79%
P/E Ratio(TTM)
60.16
EPS(TTM)
30.27
P/B Ratio
14.91
Dividend Yield
0.00%
Industry P/E
35.36
Book Value
122.12
Debt to Equity
0.22
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹357
+3.64%
Profit (Cr)
₹45.33
+9.84%
0100200300400
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26

About

CORONA Remedies Limited is a pharmaceutical company focused on women's health, cardio-metabolic, and other therapeutic segments, manufacturing and marketing branded formulations.;
CEO/MD
Niravkumar Kirtikumar Mehta
Founded in
2004
NSE symbol
CORONA

Shareholding Pattern

Apr '25
Dec '25
Mar '26
Promoters
69.00%
Foreign Institutions
22.01%
Mutual Funds
6.35%
Retail And Others
1.98%
Other Domestic Institutions
0.67%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,336.20
-4.60 (0.34%)
L
    H
    18,572.1739.465.28
    ₹766.45
    +35.00 (4.79%)
    L
      H
      18,126.3430.473.56
      ₹1,010.95
      +1.20 (0.12%)
      L
        H
        16,108.4237.512.44
        ₹1,061.60
        +6.30 (0.60%)
        L
          H
          12,958.2222.963.89
          Livesquawk
          Corona Remedies declares a final dividend of ₹10/share.
          Livesquawk
          Corona Remedies Q4 EBITDA rose 13% YoY to ₹610M from ₹540M. EBITDA margin declined to 17.3% from 18.4%, down 1.1 percentage points YoY.
          Livesquawk
          Corona Remedies reports OCF to EBITDA ratio at 87%, indicating strong cash conversion. The company highlights room for further acquisitions supported by its financial metrics.
          Livesquawk
          Corona Remedies reports ₹112 Cr cash as of Dec 31, 2022. Targets 20-25% CAGR growth for Wpladone over the next 3 years.
          2026

          19
          Jun
          Dividend
          Upcoming
          Ex date
          ₹10.00
          per share

          For each share you hold, you will receive ₹10.00
          Dividend amount₹10.00 per share
          Dividend TypeFinal
          Ex Date19 Jun ‘26
          Record Date19 Jun ‘26
          Announcement date11 May ‘26

          11
          May
          Dividend
          Announced
          ₹10.00
          per share

          For each share you hold, you will receive ₹10.00
          Dividend amount₹10.00 per share
          Dividend TypeFinal
          Ex Date19 Jun ‘26
          Record Date19 Jun ‘26
          Announcement date11 May ‘26
          11
          May
          Quarterly & Annual Result
          Release date
          2
          Feb
          Quarterly Result
          Release date
          2
          Jan
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks